Prostat biyopsisinde prostat kanseri saptanan olgularda perinöral invazyonun Gleason skoru ve pozitif kor yüzdesi ile ilişkisi

Abstract

Amaç: Bu çalışmada prostat spesifisik antijen PSA yüksekliği ve anormal rektal muayene nedeniyle transrektal ultrason TRUSG eşliğinde prostat biyopsisi alınan patolojisi prostat adenokarsinomu olarak raporlanan olgulardaki perinöral invazyonun PNI , gleason skoru ve pozitif kor yüzdesi ile ilişkisini araştırdık.Gereç ve Yöntem: Kliniğimizde 2004-2011 yılları arasında PSA yüksekliği ve anormal rektal muayene bulgusu nedeniyle TRUSG eşliğinde 10 kadran prostat biyopsisi alınan 1135 olgudan 274’ünde % 24.14 prostat adenokarsinomu saptandı. Prostat adenokarsinomu saptanan olguların 46’sında % 16.78 perinöral invazyon gözlendi. Perinöral invazyonu olan ve olmayan olgular yaş, total PSA, prostat volümü, PSA dansitesi, gleason skoru, pozitif kor yüzdesi, rektal muayene açısından karşılaştırıldı. Bunun yanı sıra olgular toplam gleason skoru ≤6 ve >6 ve pozitif kor yüzdesi ≤ % 33 ve > % 33 olmak üzere iki gruba ayrıldı ve perinöral invazyon açısından karşılaştırıldı.Bulgular: Gleason skoru ≤6 olan grupta yaş ortalaması 69.60 ± 6.56 iken gleason skoru >6 olan grupta yaş ortalaması 70.68 ± 8.34 idi p=0.153 . Gleason skoru ≤6 olan grupta ortalama PSA değeri 12.10 ± 4.57 mg/dl iken gleason skoru >6 olan grupta ortalama PSA değeri 13.11 ± 4.53 idi p=0.652 . Tüm olgularda sintigrafide kemik metastazı saptanma oranı % 31.25 iken bu oran gleason skoru ≤6 olan grupta % 6.6, gleason skoru > 6 olan grupta ise % 46.6idi. p6 olan hastalarda kemik sintigrafisinde saptanan metastaz oranı anlamlı derecede yüksekti p

Keywords

• Prostat biyopsisi,Perinöral invazyon,Gleason skoru

Relationship between the positive core percentage and Gleason score with perineural invasion in patient with prostate cancer on prostate biopsy

Abstract

Objective: In this study, we investigated relationship between the positive core percentage and gleason score with perineural invasion PNI in patients who underwent transrectal ultrasonography TRUSG guided prostate biopsy because of high prostate specific antigen PSA values and abnormal digital rectal examination.Materials and Methods: A total of 1135 patients underwent 10-quadrant TRUSG guide prostate biopsy because of high PSA values and abnormal digital rectal examination in our clinic between 2004-2011. Prostate adenocarcinoma was detected in 274 patients 24.14% . Perineural invasion was demonstrated in 46 16.78% of prostate carcinoma cases. Cases with and without PNI were compared in terms of age, total PSA, prostate volume, PSA density, gleason score, positive core percentage and rectal examination. Patients were divided into 2 groups of total gleason score ≤6 and total gleason score >6, also positive core percentages were divided into 2 groups ≤33% and > 33% and these groups were compared in terms of perineural invasion.Results: The mean age was 69.60 ± 6.56 in patients with gleason score ≤6 and 70.68 ± 8.34 in patients with gleason score > 6 p=0.153 . The mean PSA level was 12.10 ± 4.57 mg/ dl in patients with gleason score ≤ 6 and 13.11 ± 4.53 in patients with gleason score >6 p=0.652 . The rate of metastasis on bone scintigraphy was 31.25% in total, 6.6% in with gleason score ≤ 6 and 46.6% in patients with gleason score >6 p6 p

Keywords

• Prostate biopsy,Perineural invasion,Gleason score

References

1. Boyle P, Dresler C. Preventing the lung cancer epidemic. Ann Oncol. 2005; 16(10):1565-6.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71- 96.
3. Dinçel Ç. Üroonkoloji, Prostat kanserinde biyopsi. 1.Baskı. İzmir, Meta Basım Matbaacılık, 2007, p 45.
4. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol1989;142(1):71-4; dis- cussion 74-75.
5. Epstein JI: The role of perineural invasion and other biopsy characteristics as prognostic markers for localized prostate cancer. Semin Urol Oncol. 1998 ;16(3):124-8.
6. Makarov DV, Sanderson H, Partin AW, Epstein JI. Gleason score 7 prostate cancer on needle biopsy: is the prognostic difference in Gleason scores 4 + 3 and 3 + 4 independent of the number of involved cores? J Urol. 2002;167(6):2440-42
7. Axel Heidenreich , Gunnar Aus , Michel Bolla , Steven Jo- niau, Vsevolod B. Matveev , Hans Peter Schmid , Filliber- to Zattoni EAU Guidelines on Prostate Cancer 2010 p11.
8. Masieri L, Lanciotti M, Nesi G, Lanzi F, Tosi N, Minervi- ni A, Lapini A, Carini M, Serni S. Prognostic role of pe- rineural invasion in 239 consecutive patients with pat- hologically organ-confined prostate cancer. Urol Int. 2010;85(4):396-400.

9. Dall’Era, M.A., et al., Active surveillance for the manage- ment of prostate cancer in a contemporary cohort. Cancer, 2008. 112(12): 2664-70.
10. Buhmeida A, Pyrhönen S, Laato M, et al. Prognostic fac- tors in prostate cancer. Diagnostic Pathology 2006;1:4.
11. McNeal JE, Bostwick DG, Kindrachuk RA, et al. Patterns of progression in prostate cancer. Lancet 1986;1:60-63.
12. Reiter RE, deKernion JB. Carcinoma of the prostate. In: Walsh PC, Retik AB, Vaughan ED, eds. Campbells Uro- logy. 8th ed. New York: Saunders, 2002;3003-3024.
13. Ross PL, Scardino PT, Kattan MW. A catalog of prostate cancer nomograms. J Urol. 2001;165 (5):1562-8.
14. Di Blasio CJ, Rhee AC, Cho D, et al. Predicting clinical endpoints: treatment nomograms in prostate cancer. Se- min Oncol. 2003;30 (5):567-86.
15. Bastacky SI, Walsh PC, Epstein JI. Relationship betwe- en perineural tumor invasion on needle biopsy and radi- cal prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate. Am J Surg Pathol. 1993;17 (4):336-41.
16. Byar DP, Mostofi FK. Carcinoma of the prostate: prognos- tic evaluation ofcertain pathologic features in 208 radical prostatectomies. Examined by the step-section technique. Cancer 1972;30 (1):5-13.
17. Algaba F, Arce Y, Oliver A, Barandica C, et al. Prognostic parameters other than Gleason score for the daily evalua- tion of prostate cancer in needle biopsy. Eur Urol. 2005;48 (4):566-71.
18. Vargas SO, Jiroutek M, Welch WR, et al. Perineural invasi- on in prostate needle biopsy specimens. Correlation with extraprostatic extension at resection. Am J Clin Pathol. 1999;111 (2):223-8.
19. Amin M, Boccon-Gibod L, Egevad L, et al. Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens. Scand J Urol Nephrol Suppl. 2005; (216):20-33.
20. de la Taille A, Katz A, Bagiella E, et al. Perineural invasion on prostate needle biopsy: an independent predictor of fi- nal pathologic stage. Urology 1999; 54:1039-43.
21. Ali TZ, Epstein JI: Perineural involvement by benign pros- tatic glands on needle biopsy. Am J Surg Pathol. 2005 ;29(9):1159-63.
22. Passavanti G, Pizzuti V: Perineural invasion in prostatic car- cinoma treated with radical prostatectomy: the role of TR systematic biopsy. Arch Ital Urol Androl. 2007;79(1):23-5.
23. Bastacky SI, Walsh PC, Epstein JI: Relationship betwe- en perineural tumor invasion on needle biopsy and ra- dical prostatectomy capsular penetration in clinical sta- ge B adenocarcinoma of the prostate. Am J Surg Pathol. 1993;17(4):336-41.
24. Holmes GF, Walsh PC, Pound CR, et al. Excision of the neurovascular bundle at radical prostatectomy in cases with perineural invasion on needle biopsy. Urology 1999; 53:752-6.
25. Cannon GM Jr, Pound CR: Perineural invasion in prostate cancer biopsies is not associated with higher rates of positi- ve surgical margins. Prostate. 2005 1;63(4):336-40.
26. Bismar TA, Lewis JS Jr: Multiple measures of carcinoma extent versus perineural invasion in prostate needle biopsy tissue in prediction of pathologic stage in a screening po- pulation. Am J Surg Pathol. 2003;27(4):432-40.
27. Beard C, Schultz D: Perineural invasion associated with increased cancer-specific mortality after external beam radiation therapy for men with low- and intermediate- risk prostate cancer. Int J Radiat Oncol Biol Phys. 2006.1;66(2):403-7.
28. Lee IH, Roberts R: Perineural invasion is a marker for pat- hologically advanced disease in localized prostate cancer. Int J Radiat Oncol Biol Phys. 2007.15;68(4):1059-64.
29. Loeb S, Epstein JI, Humphreys EB, Walsh PC. Does perine- ural invasion on prostate biopsy predict adverse prostatec- tomy outcomes? BJU Int. 2010.105(11):1510-3.
30. Yu HH, Song DY: Perineural invasion affects biochemical recurrence-free survival in patients with prostate cancer treated with definitive external beam radiotherapy. Uro- logy. 2007;70(1):111-6.